Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis

Brain and Development

Volumn 32, Issue 6, 2010, Pages 463-466

  Aydin, Ömer Faruk ^a,d   Ichiyama, Takashi ^b   Anlar, Banu ^c  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HACETTEPE UNIVERSITY   (Turkey)

^d DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

Author keywords

Cytokines; Immune; Subacute sclerosing panencephalitis; Th1; Th2; Viral

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 14; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMETRY; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; REGULATORY T LYMPHOCYTE; SUBACUTE SCLEROSING PANENCEPHALITIS; TH1 CELL;

CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; INTERLEUKINS; MALE; SUBACUTE SCLEROSING PANENCEPHALITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952553956     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2009.04.018     Document Type: Article

References (19)

1. Hara T., Yamashita S., Aiba H., Nihei K., Koide N., Good R.A., et al. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol 2000, 6(2):121-126.
2. Dhib-Jalbut S., Jacobson S., McFarlin D.E., McFarland H.F. Impaired human leukocyte antigen-restricted measles virus-specific cytotoxic T-cell response in subacute sclerosing panencephalitis. Ann Neurol 1989, 25:272-280.
3. Karp C.L., Wysocka M., Wahl L.M., Ahearn J.M., Cuomo P.J., Sherry B., et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996, 273(5272):228-231.
4. Schneider-Schaulies J., Schneider-Schaulies S., Ter Meulen V. Differential induction of cytokines by primary and persistent measles virus infections in human glial cells. Virology 1993, 195:219-228.
5. Yalaz K., Anlar B., Oktem F., Aysun S., Ustacelebi S., Gurcay O., et al. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology 1992, 42(3 Pt 1):488-491.
6. Cook E.B., Stahl J.L., Lowe L., Chen R., Morgan E., Wilson J., et al. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods 2001, 254(1-2):109-118.
7. Ichiyama T., Siba P., Suarkia D., Reeder J., Takasu T., Miki K., et al. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea. Cytokine 2006, 33(1):17-20.
8. Yentür S.P., Gürses C., Demirbilek V., Yilmaz G., Onal A.E., Yapici Z., et al. Alterations in cell-mediated immune response in subacute sclerosing panencephalitis. J Neuroimmunol 2005, 170(1-2):179-185.
9. Anlar B., Guven A., Köse G., Okur H., Kose O., Aydin O.F., et al. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients. J Neuroimmunol 2005, 163(1-2):195-198.
10. Saruhan-Direskeneli G., Gürses C., Demirbilek V., Yentür S.P., Yilmaz G., Onal E., et al. Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis. Cytokine 2005, 32(2):104-110.
11. Mistchenko A.S., Fornari M.C., Viegas M., Barrero P.R., Diez R.A. Detection of interleukin 10 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis. J Neurovirol 2005, 11:66-69.
12. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001, 12:53-72.
13. Trinchieri G. Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 1993, 14(7):335-338.
14. Groux H., Powrie F. Regulatory T cells and inflammatory bowel disease. Immunol Today 1999, 20(10):442-445.
15. Berthelot J.M., Maugars Y. Role for suppressor T cells in the pathogenesis of autoimmune diseases (including rheumatoid arthritis). Facts and hypotheses. Joint Bone Spine 2004, 71(5):374-380.
16. Liotta F., Cosmi L., Romagnani P., Maggi E., Romagnani S., Annunziato F. Functional features of human CD25+ regulatory thymocytes. Microbes Infect 2005, 7(7-8):1017-1022.
17. O'Garra A., Vieira P.L., Vieira P., Goldfeld A.E. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 2004, 114(10):1372-1378.
18. Rouse B.T., Sarangi P.P., Suvas S. Regulatory T cells in virus infections. Immunol Rev 2006, 212:272-286.
19. Eggena M.P., Barugahare B., Jones N., Okello M., Mutalya S., Kityo C., et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005, 174(7):4407-4414.